Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials

Objectives: This study aims to explore the weight loss effect and safety of semaglutide as a conventional anti-obesity drug systematically in obese or overweight patients without diabetes. Methods: The randomized controlled trials (RCTs) of semaglutide in obese or overweight patients without diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xueqin, Hua, Xiaoli, Wang, Xu, Xu, Wanbin, Zhang, Yu, Shi, Chen, Gu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515581/
https://www.ncbi.nlm.nih.gov/pubmed/36188627
http://dx.doi.org/10.3389/fphar.2022.935823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515581/
https://www.ncbi.nlm.nih.gov/pubmed/36188627
http://dx.doi.org/10.3389/fphar.2022.935823

Ejemplares similares